KRBPQ — Kiromic Biopharma Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Kiromic Biopharma Receives Notice Of Delisting From Nasdaq
Brief: Kiromic Biopharma Says Frank Tirelli Informs The Board That He Is Resigning His Position As Director Of Co
Brief: Kiromic Biopharma Inc - On October 21, Issued A 25% Senior Secured Convertible Promissory Note To An Accredited Investor
U.S. STOCKS ON THE MOVE-Alphabet, Sylvamo, Compass
U.S. STOCKS ON THE MOVE-Pinterest, Take-Two, energy sector
U.S. STOCKS ON THE MOVE-Conagra Brands, Provention Bio, Constellation Brands
Brief: Kiromic Biopharma Announces FDA Feedback From Type B Pre-Ind Meeting Confirms Deltacel Development Strategy
Kiromic BioPharma up on positive FDA feedback for lung cancer therapy, job cuts
Brief: Kiromic Biopharma Received Letter From Nasdaq That Co Has Been Granted 180-Day Extension To March 13, 2023 To Regain Compliance
Brief: Kiromic Biopharma Files For Firm Commitment Public Offering Of Up To 62.5 Mln Shares Of Common Stock
Brief: Kiromic BioPharma Achieves Milestone With Timely Completion Of Expanded CGMP Manufacturing Facility To Support Cell Therapy Oncology Pipeline
Brief: Kiromic Biopharma Pipeline To Prioritize A New Gamma Delta T-Cell Product Candidate
U.S. STOCKS ON THE MOVE-J.Jill Inc, Roku Inc, DocuSign Inc
U.S. STOCKS ON THE MOVE-Annexon Inc, Mirati Therapeutics, Biodesix Inc
U.S. STOCKS ON THE MOVE-Bluebird bio Inc, JanOne Inc, J.M. Smucker Co
U.S. STOCKS ON THE MOVE-Chico's FAS Inc, Chevron Corp, Union Pacific Corp
U.S. STOCKS ON THE MOVE-Kohl's Corp, Target Corp, Veru Inc
Kiromic BioPharma surges on research agreement to expand cancer therapy pipeline
Brief: Kiromic Biopharma Expands Gamma Delta T Cell Product Pipeline With New Sponsored Research Agreement